Gerresheimer adapts its eye drop bottle to new FDA requirements

Gerresheimer adapts its eye drop bottle to new FDA requirements
Gerresheimer adapts its eye drop bottle to new FDA requirements

Düsseldorf/Barcelona, October 4, 2016 – Gerresheimer is one of the world’s leading suppliers of plastic eye drop bottles. It recently modified the closure system on its Type A dropper bottle to the FDA’s new requirements. Now the tamper evident ring stays firmly affixed to bottle once it has been opened.

The tamper evident ring is important because it tells the user that the product hasn’t been opened since filling. This guarantees that the bottle contains the original pharmaceutical and that nobody else has previously opened or used it. Although that’s important with all medications, it’s particularly important with eye drops, which shouldn’t be administered if they are contaminated. “Sometimes it’s the little ideas that make a big improvement to a product,” said Marek Misczcak, Head of Research & Development at Gerresheimer and primary packaging expert for ophthalmic applications. “Before the modification, the tamper evident rings were loose on the bottle neck after opening. Unless the user removed the ring, it constituted a potential hazard. That’s why fixing the tamper evident ring in place is a good idea that improves safety.” None of the other eye drop bottle specifications have changed.

More information about the Gerresheimer eye drop bottle System A

About Gerresheimer


Gerresheimer is a leading global partner to the pharma and Cross section of the eye drop bottle with fixed TE ringhealthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 11,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.

Contact us!

Communication & Marketing
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com

Press
Phone: +49 211 61 81 246
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com